These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
164 related articles for article (PubMed ID: 9848437)
21. Effect of 1 mg/day finasteride on concentrations of serum prostate-specific antigen in men with androgenic alopecia: a randomised controlled trial. D'Amico AV; Roehrborn CG Lancet Oncol; 2007 Jan; 8(1):21-5. PubMed ID: 17196507 [TBL] [Abstract][Full Text] [Related]
22. A randomized, double-blind controlled study of the efficacy and safety of topical solution of 0.25% finasteride admixed with 3% minoxidil vs. 3% minoxidil solution in the treatment of male androgenetic alopecia. Suchonwanit P; Srisuwanwattana P; Chalermroj N; Khunkhet S J Eur Acad Dermatol Venereol; 2018 Dec; 32(12):2257-2263. PubMed ID: 29972712 [TBL] [Abstract][Full Text] [Related]
23. Changes of metabolic profile in men treated for androgenetic alopecia with 1 mg finasteride. Duskova M; Hill M; Starka L Endocr Regul; 2010 Jan; 44(1):3-8. PubMed ID: 20151762 [TBL] [Abstract][Full Text] [Related]
24. Depression circumstantially related to the administration of finasteride for androgenetic alopecia. Altomare G; Capella GL J Dermatol; 2002 Oct; 29(10):665-9. PubMed ID: 12433001 [TBL] [Abstract][Full Text] [Related]
25. Therapeutic hotline. Treatment of androgenic alopecia with finasteride may result in a high grade prostate cancer in patients: fact or fiction? Lynn R; Krunic A Dermatol Ther; 2010; 23(5):544-6. PubMed ID: 20868409 [TBL] [Abstract][Full Text] [Related]
26. Effect of finasteride on risk of prostate cancer: how little we really know. Rubin MA; Kantoff PW J Cell Biochem; 2004 Feb; 91(3):478-82. PubMed ID: 14755678 [TBL] [Abstract][Full Text] [Related]
27. Finasteride in the treatment of Taiwanese men with androgenetic alopecia: a 12-month open-label study. Lin JH; Chen WC Kaohsiung J Med Sci; 2002 Aug; 18(8):379-85. PubMed ID: 12476680 [TBL] [Abstract][Full Text] [Related]
28. Prevention of prostate cancer with finasteride. Burke HB N Engl J Med; 2003 Oct; 349(16):1569-72; author reply 1569-72. PubMed ID: 14562806 [No Abstract] [Full Text] [Related]
29. A review of hormonal therapy for female pattern (androgenic) alopecia. Scheinfeld N Dermatol Online J; 2008 Mar; 14(3):1. PubMed ID: 18627703 [TBL] [Abstract][Full Text] [Related]
30. Adverse Effects of 5-Alpha Reductase Inhibitor Therapy in Men With Androgenetic Alopecia: Is There Cause for Concern? Arias-Santiago S; Camacho-MartÃnez FM Actas Dermosifiliogr; 2016 Nov; 107(9):709-711. PubMed ID: 27436801 [No Abstract] [Full Text] [Related]
31. The potential application of finasteride for chemoprevention of prostate cancer. Gormley GJ; Brawley O; Thompson I Ann N Y Acad Sci; 1995 Sep; 768():163-9. PubMed ID: 8526345 [No Abstract] [Full Text] [Related]
32. Caspase-1 level is higher in the scalp in androgenetic alopecia. de Rivero Vaccari JP; Sawaya ME; Brand F; Nusbaum BP; Bauman AJ; Bramlett HM; Dietrich WD; Keane RW Dermatol Surg; 2012 Jul; 38(7 Pt 1):1033-9. PubMed ID: 22404322 [TBL] [Abstract][Full Text] [Related]